The pioneering “Diagnostic Tampon” already utilises PCR testing technology to allow women and assigned female at birth (AFAB) individuals to screen their vaginal microbiome and test for STIs, such as chlamydia, gonorrhoea, trichomonas, mycoplasma and ureaplasma, from the comfort and convenience of their own home. 

Daye is going one step further by introducing a screening kit for 14 high-risk HPV infections. 

Most strains of HPV do not present with any symptoms, which is why proactive screening is crucial. HPV infections are also incredibly common, eight in 10 people will become infected with HPV at least once in their lifetime, however, many still lack knowledge about the management of HPV and its potential complications.